Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial - Concepedia

Concepedia

Publication | Open Access

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial

DOI Full Paper Access

15

Citations

29

References

2022

Year

Kara‐Louise Royle, Amy Beth Coulson, Karthik Ramasamy, David A. Cairns, Anna Hockaday, Sergio A. Quezada, Mark T. Drayson, Martin Kaiser, Roger G. Owen, Holger W. Auner,

Abstract

ISCRTN46841867.

References

	Year	Citations

Page 1